Evonik Acquires Pharmaceuticals Business of SurModics
Evonik Industries AG recently announced it has reached an agreement to acquire the Pharmaceuticals business of SurModics, Inc. headquartered in
“Evonik is a strategic partner and one of the world’s leading solution providers to the pharmaceutical industry. By acquiring the polymer and formulation services businesses of SurModics, we continue to expand our position in this important market”, said Dr. Klaus Engel, Chairman of Evonik’s Executive Board.
SurModics Pharmaceuticals, Inc., an affiliate of SurModics, Inc., is a leader in injectable drug delivery systems. The new business includes two world-class facilities for the development and manufacturing of polymers and drug delivery systems. The company is located in
“With the Lakeshore Biomaterials portfolio of polymers and associated range of established formulation development services, we acquire leading expertise and capabilities for the development and manufacturing of innovative drug delivery solutions. This is a consistent extension of our current pharmaceutical product and service platform,” added Dr. Jean-Luc Herbeaux, Head of the Health Care business at Evonik.
SurModics Pharmaceuticals designs and produces bioresorbable polymers (marketed under the brand Lakeshore Biomaterials) and possesses expertise and facilities to carry out all phases of pharmaceutical product development up to commercial manufacturing. The business focuses on the development of injectable drug delivery systems that systemically or locally release APIs within a period of up to several months. Formulation approaches include bioresorbable mi
With its Pharma Polymers product line, Evonik is a leading developer and producer of functional pharmaceutical excipients. Based on its well-known EUDRAGIT product portfolio, the company develops coatings and matrix systems that provide controlled release of APIs in tablets and other oral dosage forms. In March 2011, this oral drug delivery platform was complemented with the addition of the RESOMER polymers, which are used for controlled-release injectables and bioresorbable implants as well as in medical devices.
Evonik is one of the world leaders in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency, and globalization. In 2010, about 80% of the Group’s chemicals sales came from activities where it ranks among the market leaders. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Total Page Views: 1346
